Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
University of Nebraska
National Institutes of Health Clinical Center (CC)
Travera Inc
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Instituto do Cancer do Estado de São Paulo